May 11th of the Lunar Calendar

NowadaysLookSummer graduation song at station B

My colleague said it was taken at his alma mater

I miss my student days

While envious of colleagues

So there are so many stars in the school

In the end, he said he was used to it

I have seen many stars come to school in the four years of university

Here are the other big news today

# Sichuan Bitcoin mining farm collectively cuts off power netizens: Nice job

(China Fund News) It is reported that due to policy reasons, China and even Sichuan, the world’s most important gathering place for Bitcoin mining machines, will usher in a large area of ​​mining machines. According to calculations, the shutdown load is about 8 million kilowatts. Following Inner Mongolia and Xinjiang, Sichuan, which is dominated by clean energy and hydropower, also failed to become the last bastion of Bitcoin mining in China.

A document “Notice of the Sichuan Provincial Development and Reform Commission and the Sichuan Provincial Energy Bureau on the Cleanup and Shutdown of Virtual Currency “Mining” Projects” shows that for virtual currency “mining”, relevant power companies in Sichuan need to do so on June 20. The screening, clean-up and shutdown work was completed a few days ago.

According to data from btc.com, the current average computing power of the entire Bitcoin network is 126.83 EH/s, which is nearly 36% lower than the historical high of 197.61 EH/s (May 13). At the same time, Bitcoin mining pools with Chinese backgrounds such as Huobi Pool, Binance, AntPool and Poolin have fallen sharply in their computing power. The decline in computing power in the past 24 hours has been 36.64%, 25.58%, 22.17%, and 8.05%, respectively.

:plus! Big! force! degree!

# The supply chain has received the design proposal of Huawei Mate 50, and the delivery time is to be determined

(House of IT) According to China Securities Journal, Huawei Supply Chain Company stated that they have received Huawei Mate 50 mobile phone design. “Huawei did not say that it will cancel the release, but the time for mass production and supply has not yet been determined.”

At present, Huawei officials have not yet officially responded to the above news. However, some Huawei coefficient code bloggers said that they will not be cancelled, but will be postponed, and will do their best to launch this year.

According to the period of Huawei’s previous release of new products, the P50 series of mobile phones should have been released in March, and the Mate 50 series should be launched in September this year and equipped with a new generation of Huawei’s self-developed chips.

: Tears again.

# Xiaomi’s three new screens broke the news: MIX4 is FHD+ Huaxing screen, and there will be direct screens next year

(House of IT ) Digital blogger @ 数码闲聊站 recently broke a lot of information about new under-screen cameras and new folding screens from various manufacturers. Although some did not clearly indicate that they are Xiaomi, I believe there are still some small partners who can see it.

Although the news is complicated, there are actually three products about Xiaomi. Digital blogger @ ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ release, Mi MIX4 and MIX FOLD will be released this year. , The latter supports 90/120Hz for both internal and external screens, while the third model is a direct-screen model with 1080p + 90Hz refresh rate and will be released next year.

Combined with the news of @数码闲聊站, the MIX FOLD under-screen version will be equipped with Qualcomm Snapdragon 888 chip, with 5000mah battery, and the rear main camera is still 108MP; while Xiaomi MIX4 will use the upgraded version of the Huaxing Optoelectronics under-screen solution shown last year , The hyperboloid AMOLED screen is expected to be around 6.67 inches, or it will support high refresh rates.

: There are so many people looking forward to MIX4.

# my country’s new crown vaccination has more than 1 billion doses, all regions continue to go all out to ensure vaccine supply

(CCTV )The National Health Commission announced today (June 20) that as of June 19, 31 provinces, autonomous regions, municipalities, and Xinjiang Production and Construction Corps had reported a total of 1.010.48 million doses of COVID-19 vaccine.

my country’s new crown vaccination has more than 1 billion doses, and all localities continue to make every effort to ensure the supply of vaccines, increase the organization and implementation of vaccination, and introduce a number of convenient measures to facilitate the people’s vaccination.

At present, all localities are taking effective measures to ensure the smooth progress of vaccination work.

: The second shot is over!

South Africa throws away 2 million doses of COVID-19 vaccine due to contamination incident. Photo: Reuters According to RT (Russia) news agency (Russia), the South African Health Products Administration (SAHPRA) has decided not to deploy vaccination for 2 million doses of Johnson & Johnson vaccine being stored at a facility in the city of Gqeberha. , as the raw materials for their production were affected by a contamination incident at the factory in Baltimore (USA). The decision comes after the US Food and Drug Administration (FDA) said that millions of doses of vaccine produced at Johnson & Johnson’s Emergent BioSolutions facility in the US city of Baltimore were not suitable for use in the United States. use. “Based on what has been announced by the FDA, batches of vaccines being stored in our Gqeberha have been affected. The batches of these vaccines correspond to about 2 million doses,” South Africa’s Acting Health Minister Mmamoloko Kubayi-Ngubane said on June 13. These doses of the vaccine have not and will not be used to immunize South Africans, she added. SAHPRA chief executive, Dr Boitumelo Semete, also confirmed the batch of vaccines “cannot be widely distributed.” Meanwhile, South Africa’s health watchdog said in a statement that a new batch of about 300,000 doses of Johnson & Johnson’s COVID-19 vaccine has been approved by the FDA and will be shipped to South Africa at a later date. some point. The agency did not disclose the exact date the shipments arrived. However, Mr. Semete acknowledged that the problem with Johnson & Johnson’s vaccine had a significant negative impact on South Africa’s vaccine deployment strategy. As of June 13, South Africa, the country hardest hit by the COVID-19 epidemic in Africa, has recorded about 1.7 million cases of COVID-19 and over 57,000 deaths. However, the country with a population of about 58.5 million people has only injected 183,000 doses of the vaccine to its people, as of June 9, according to the World Health Organization (WHO). South Africa is also one of the countries that is campaigning to give up patents for a COVID-19 vaccine to allow all countries to produce generic versions at low cost. “If we want to save lives and end the pandemic, we need to expand and diversify our production, put medical products into treatment, and fight and stop the pandemic for as many people as possible,” the president said. South Africa Cyril Ramaphosa speaks at a meeting with G7 countries in the UK on June 13.

Deliveries to companies Farms are waiting for more vaccine

Status: 14.06.2021 12:44 p.m.

Company doctors have been able to vaccinate their employees for a week. But the amount of vaccine allocated is nowhere near sufficient. In the second week, fewer vaccine doses are delivered than in the first. From Jens Eberl, WDR BMW has big plans. The automobile manufacturer has set up a total of 29 vaccination lines at its locations in Germany. In Munich alone there are six vaccination lines at two locations. The company said it could do up to 2,500 vaccinations a day. This means that the entire workforce in Germany can be vaccinated within a few weeks. The problem: there isn’t enough vaccine. A little more than 5000 employees were vaccinated in the first week. The situation is similar with the consumer goods manufacturer Henkel. A vaccination center was set up in a company building in the immediate vicinity of the factory premises in Düsseldorf. Up to 1500 employees per week can be vaccinated. In the first week, however, there were only 640.

Fewer vaccine doses in the second week

“Many companies have prepared themselves really well,” says Wolfgang Panter, President of the Association of German Company and Company Doctors (VDBW). “6300 company doctors are available nationwide and have ordered vaccines.” But it is only arriving slowly. The distribution is based on the number of company doctors in the company. Last week there were 102 doses per doctor. This week it should be 84. “Originally, 804 cans per head were planned, but it was clear that this would never be the case,” said Panter. The company doctors are now relying heavily on July. Here one reckons that the vaccination turbo will be switched on. Be prepared.

FAQ 06/08/2021

High demand from the staff

At Thyssenkrupp, vaccinations are carried out every five minutes at the Essen site, on four vaccination lines, with seven doctors from 8 a.m. to 5 p.m. Should more vaccine be delivered, vaccinations can also be carried out in the evening and on weekends and a 5th vaccination line can also be used. 50,000 people work at Currenta, which manages and operates one of the largest chemical sites. They had ordered 20,000 doses here; if these had arrived, the vaccination would be finished in two to three weeks. But only 3000 came. According to the company, the vaccination lines of Deutsche Telekom have a capacity of up to 10,000 vaccinations per week. Telekom has 89,000 employees in Germany. Due to the approval of priority group 3 by the federal states, vaccinations had already been carried out in the company. The company expects up to 30,000 employees to take advantage of the opportunity to be vaccinated by company doctors. Telekom has set up 18 vaccination lines nationwide for this purpose.

06/02/2021

IT facilitates rapid processes

Many companies have also adapted their IT to vaccinate. For example, BASF has developed its own online booking system together with an IT service provider. Employees can use this to register. The navigation along the entire Impfstraße is completely digitized from check-in to check-out. The vaccination center went into operation on April 14th. Up to and including Friday, around 16,000 BASF employees had received an initial vaccination. Initially, the vaccination sequence prescribed by the state of Rhineland-Palatinate was followed and priority groups II and III were vaccinated. Since June 7, all BASF employees at the Ludwigshafen site have been able to register for a vaccination appointment. At the Vonovia real estate group, a random generator determines who receives a vaccination offer for which location based on the activity performed. First, the random number generator selects employees with direct customer contact.

Prioritization canceled in many places

In the meantime, many companies have completely removed the prioritization. The Deutsche Post says that there is no longer any personal prioritization in the sequence of vaccinations. “Through the choice of location and the allocation of appointments, we ensure that employees in the operational area have at least equal access to operational vaccination appointments,” says the company. At RWE, employees have been able to make appointments using an online tool or by telephone since last Monday. RWE does not plan to prioritize vaccinations. The President of the Association of German Company and Company Doctors has established that every company has a different approach to prioritization. From his point of view, employees who are exposed to a higher risk should still be given preference, for example field staff or fitters; People who have a lot of contacts. Of course, you can’t dictate that, says Panter.

Thanh Nhan Hospital deploys AstraZeneca’s Covid-19 vaccine for medical staff. Accordingly, this number of vaccines is distributed by the Hanoi Department of Health to districts, towns. Districts, towns and cities have prepared to deploy the third phase of Covid-19 vaccination according to the plan of the Ministry of Health and the guidance of the Central Institute of Hygiene and Epidemiology. It is expected that the vaccination against Covid-19 in this batch will end in July 2021. The Covid-19 vaccine in the 3rd and 4th waves will focus on giving the first dose to priority subjects in the spirit of Resolution 21/NQ-CP of the Government, that is, people working in medical facilities. health (medical staff working at domestic and non-public health facilities have not been vaccinated); participants in epidemic prevention and control; staff directly participating in service at concentrated isolation areas; members of the City’s Steering Committee for Epidemic Prevention and Control, the Health Sector Steering Committee for Epidemic Prevention and Control, the Steering Committees at all levels and branches; Community Covid-19 Team members have not been vaccinated… In addition, those who have received the 1st dose will be given the 2nd dose after being given the next round of vaccines (batches 5 and 6). Priority subjects received 1 dose of vaccine and the interval between 2 injections was at least 8 weeks. Tran Thi Nhi Ha, Director of the Hanoi Department of Health, said that Hanoi puts vaccination safety first. Districts, towns need to proactively arrange safe vaccination points and strengthen inspection and supervision of vaccination points, ensuring full compliance with the vaccination process as prescribed by the Ministry of Health. Previously, Hanoi deployed the first phase of Covid-19 vaccination for more than 8,400 people and the second phase for more than 53,000 people. Step 1: Visit https://www.bluezone.gov.vn or download directly at App Store or CH Play. Step 2: Once downloaded, the application will ask for permission to use Bluetooth to record contact with other Bluezone installed users. If Bluetooth is not open, drag the status bar and turn on Bluetooth; or go to Settings, select Bluetooth and turn it on. Step 3: Once the installation is done, click Scan Around. If someone near you less than 2m has used Bluezone, the application will automatically identify these users and put them in the contact list.

All of these vaccines are allocated to priority subjects according to Resolution 21 and localities with industrial parks. Vaccines for COVID-19. Photo: Times of India. In addition, from now until the end of the third quarter, Vietnam will also receive an additional 2 million doses of AstraZeneca’s vaccine ordered by the Ministry of Health through VNVC. In the third quarter, information from the pharmaceutical company Pfizer said that 3 million doses of vaccine can be shipped to Vietnam, the rest will be concentrated in the fourth quarter. However, the specific time and quantity may change due to dependents. of the world situation. According to Professor Dang Duc Anh, the COVID-19 vaccine has a very short shelf life, only about 6 months. Meanwhile, the time from the production facility to Vietnam takes about 2 months, so it only takes 3-4 months to deploy the injection. In particular, Pfizer’s vaccines must be stored at deep minus temperatures (-70 degrees Celsius). If the temperature is 2-8 degrees Celsius, this vaccine is only used for one month. Therefore, in the coming time, the Ministry of Health will coordinate with units of the Ministry of National Defense across the country to ensure the preservation and transportation of vaccines to the injection point in the shortest time. Up to this point, Vietnam has urgently approved four COVID-19 vaccines: AstraZeneca, Sputnik V, Sinopharm and Pfizer. Vietnam aims to have 150 million doses of COVID-19 vaccine this year for at least 70-80% of the population, to form herd immunity. However, only 4 batches of AstraZeneca’s vaccine have arrived in Vietnam with a total of nearly 2.9 million doses. Earlier, Minister of Health Nguyen Thanh Long stated that Vietnam is facing the 4th wave of COVID-19 epidemic with the Delta variant of SARS-CoV-2 capable of spreading quickly and widely. The Vietnamese government is drastically directing epidemic prevention and control measures to soon stabilize the situation. One of Vietnam’s priorities in COVID-19 prevention is to have a COVID-19 vaccine early and to implement broader vaccination coverage for the population. Therefore, in parallel with efforts to find, negotiate and discuss with partners and vaccine manufacturers to bring vaccines to Vietnam, the Ministry of Health and related ministries and branches also focus on developing domestic vaccines to gradually ensure vaccine autonomy. At the same time, Vietnam also participates in COVAX’s global vaccine supply mechanism.

“I have a strategy and I will publish it.” Biden said when asked about the vaccine strategy for the world before boarding Air Force One to fly to the UK for the G-7 summit. The US will donate 500 million doses of the Pfizer vaccine to the world. (Photo: CNN) Sheet The Times said Mr Biden would appear alongside Pfizer CEO Albert Bourla to make the announcement. According to the AP , of these 500 million doses, 200 million doses will be shared this year. The rest will be donated in early 2022. Washington Post was the first newspaper to publish this information. Many newspapers later cited sources confirming the above information. The US is facing increasing pressure to draw up a plan to share vaccines with the world as its vaccine campaign is inching towards the finish line. Last week, the White House announced plans to allocate the first 25 million doses of the vaccine, with 19 million going to COVAX and 6 million to current COVID-19 hotspots including India. These vaccines are among the 80 million doses of vaccines the US has pledged to share with the world this month.

Indonesian health experts are concerned about the risk of an increase in the number of new cases, due to variants of Covid-19 and a large number of people traveling between many areas after Ramadan. Indonesian health workers vaccinate people. Photo: Reuters In another development, Indonesian President Joko Widodo said on June 9 that the government’s goal in July is to reach the milestone of 1 million doses of vaccination per day. “I want the vaccination of the population to reach 700,000 doses a day this month, and continue to increase. By July 2021, we can reach our goal of 1 million doses per day,” he said. US announced to donate 500 million doses of vaccine USA Today news agency today (June 10) said that the administration of US President Joe Biden will announce a plan to donate 500 million doses of Pfizer’s Covid-19 vaccine to more than 90 countries over the next two years. A senior US official said Biden will announce his plan to donate the vaccines at the G7 summit in the UK this week. The vaccines will be distributed through COVAX, to help deliver them to more low-income countries. Earlier this month, Mr. Biden pledged to share about 7 million doses of Covid-19 vaccine to Asian countries and territories such as India, Thailand, Laos, Bangladesh and Vietnam. .. Russia strengthens epidemic prevention in the capital The authorities of Moscow, Russia said they will continue to strengthen disease prevention and control such as requiring people to wear medical masks and gloves in public spaces such as restaurants and bars amid the number of infections in the country. This city has recently grown strongly. Channel News Asia quoted data from the Russian Ministry of Health on June 9, saying that in the past 24 hours, the country recorded an additional 10,407 infections. In particular, in Moscow, the authorities have recorded 4,142 new infections, the highest level since mid-January. “The epidemic situation is getting worse in Moscow due to the increasing number of infections,” said official Yevgeny Danchikov. China approves 7th vaccine According to the Global Times on June 9, China approved the 7th Covid-19 vaccine. The vaccine was developed by the Biomedical Research Institute of the Chinese Academy of Medical Sciences in Kunming City, China. Yunnan province, southwestern China. According to China’s Science and Technology Daily, phase 1 and 2 clinical trials have shown that the vaccine is effective, which can quickly induce an immune response in the injected person’s body. On the same day, China’s National Health Commission (NHC) said that more than 808 million doses of the Covid-19 vaccine had been distributed across China as of June 8. Some other developments on the epidemic Updated at 5 am on June 10 of the Worldometers statistics page, the Covid-19 epidemic is raging in 220 countries and territories, infecting more than 175.1 million people and claiming the lives of more than 3, 7 million patients. The number of recoveries reached over 158.9 million cases. India continues to experience a terrible day with the number of new infections reaching more than 93,900 and the death toll over 6,100. So far, the country has a total of 29.1 million positive cases and more than 359,000 deaths. Brazil also faces serious contagion and death when it records 84,600 new infections to the list of more than 17.1 million patients, and more than 2,200 victims to a total of 479,500 deaths from Covid-19. Tuan Tran

People wait for their turn to get vaccinated against COVID-19 in Beijing. Photo: AP According to CNBC, within just 5 days of May, China injected 100 million doses of the COVID-19 vaccine to its people. Health officials hope to be able to vaccinate 80% of its 1.4 billion population by the end of 2021. As of June 2, China has injected a total of over 704 million doses of vaccine, of which half were administered in May. The total number of doses of COVID-19 vaccine that China has given to the population accounts for about one-third in one. ,9 billion doses of vaccine are distributed globally. The call to vaccinate is from all walks of life. Companies inject workers, schools urge students and teachers to immunize, local authorities urge people to vaccinate. According to Our World in Data, in 7 days, China is injecting an average of 19 million doses per day. With a population a quarter of China’s, the US only injected 3.4 million doses / day in April – when the vaccination campaign was operating at full speed. A medical worker administers a COVID-19 vaccine at a vaccination site in Shanghai, China. Photo: THX/VNA On May 30, Zhong Nanshan, the head of an expert group of the National Health Commission of China, said that 40% of the Chinese population has been vaccinated with at least one dose, and the government’s goal is to fully immunize all patients. this number at the end of June. In the capital Beijing, 87% of people have received at least one dose of the COVID-19 vaccine. Vaccination in Beijing is easy because there are hundreds of vaccination service points throughout the city. Vaccination buses are parked right in crowded areas such as city centers and commercial centers. However, vaccination in other areas is not as easy as in the capital. Ms. Zhou Hongxia, a resident of Lanzhou, Gansu province, said: “I started waiting in line for the injection at 9am and didn’t get the injection until 6pm. It’s tiring. When I returned, there were still people waiting.” Ms. Zhou’s husband couldn’t even schedule a vaccination. On May 31, government officials said they were working to ensure the supply of COVID-19 vaccine is distributed more evenly. Not only focusing on inoculating people in the country, China also injects its citizens abroad when donating vaccines to Thailand, part of which is used to vaccinate the Chinese before giving them to Thai people. Globally, China has injected more than 500,000 citizens abroad. Before the domestic vaccination campaign accelerated in recent weeks, many Chinese people were in no hurry to get vaccinated because China had almost no cases in the community thanks to tight border controls and mandatory isolation. Recently, China has appeared many small clusters of infection and is suppressing the cluster in Guangzhou. According to analysts, despite the uneven distribution of COVID-19 vaccines, Chinese manufacturers have hardly had problems with the scale of production. Both companies that produce most of the COVID-19 vaccines being used in China, Sinovac and Sinopharm, have drastically increased production, built new factories and converted existing factories to produce COVID-19 vaccines. . Vaccines of Sinovac Biotech (China) at a vaccination center in Bangkok, Thailand on May 12, 2021. Photo: THX/VNA Vaccines from Sinovac and one from Sinopharm have been approved for emergency use by the World Health Organization. “Where in the world can match China in terms of construction speed? How long does it take China to build field hospitals? Just a few days.” Sinovac said it has doubled production capacity to 2 billion doses/year, while Sinopharm said it can produce 3 billion doses/year. From the beginning of the year to the end of May, Sinovac produced 540 million doses of the COVID-19 vaccine. Government support is crucial for vaccine manufacturers at every stage. Sinopharm said that right from the start of the vaccine research, it had borrowed a laboratory at a government research center. Chinese vaccine companies largely do not depend on imported products in the production process, so the scenario of shortage of raw materials and ingredients like the Serum Institute in India should be avoided. As of June 4, China had 91,194 cases of COVID-19, of which 4,636 died.

Tokyo’s overlapping messages have drawn criticism, as the country lags behind countries like the US in vaccinations. Japan has recorded about 695,000 new coronavirus infections and 12,000 deaths. The country is facing a new wave of infections in the context of the Tokyo Olympics approaching. Many Japanese prefectures are still in a state of emergency to limit the spread. Tokyo has contracts with three suppliers, under which it will have 120 million doses of AstraZeneca, 50 million doses of Moderna (to be completed by the end of September) and is negotiating an additional 50 million doses, along with 194 doses of Pfizer calculated. until the end of this year. With this number, Japan will have enough vaccine to vaccinate the entire population of 126 million people, according to Japan Times . On May 21, the country approved the use of the Moderna vaccine for people 18 years of age and older, but AstraZeneca has not yet been approved for the public. The Japanese government’s vaccination program is using the Pfizer vaccine, while the Moderna vaccine will be rolled out from next week in Tokyo and Osaka. Many concerns when using vaccines The biggest barrier to new vaccine doses available in Japan is the screening process, which evaluates efficacy and safety based on clinical trial data. Like other covid-19 vaccines, doses of AstraZeneca are classified as an emergency measure in pandemic response in Japan, used only when the Health Ministry allows the city governments. The licensing action requires a separate approval process, which includes a subcommittee on vaccines from the Ministry of Health meeting to discuss the use of the AstraZeneca vaccine in Japan in a broader context based on: fruit; alternatives from Pfizer and Moderna; Japanese immunization schedule and potential side effects. Pfizer’s covid-19 vaccine is shipped in Tokyo, Japan, February 16. Photo: AP. However, the road to deploying vaccines in the real world is still fraught with thorns, due to growing concerns about potential side effects of vaccines. There have been reports of a small number of people receiving the AstraZeneca vaccine developing blood clots, including in some cases death. This condition usually occurs in younger age groups. The UK reported 79 cases of AstraZeneca vaccination at the end of March, out of 20.2 million doses administered. As a result, 19 people died, of which 11 were under the age of 50. This has led some countries to restrict vaccination of the elderly – a direction that seems unlikely for Japan. The plan is still open Japan has given the Pfizer vaccine to the elderly and will start providing the Moderna vaccine at mass vaccination sites on May 24. The country has guaranteed enough doses for more than 122 million people, of which more than 110 million people aged 16 and over are allowed to receive the vaccine. Vaccination site for people 65 and older in Otsu, Shiga Prefecture, Japan on April 12. Photo: Kyodo. Given that Japan already has sufficient supplies for the vaccination campaign for the elderly, with a goal of completing it by the end of July, the use of the AstraZeneca vaccine for this age group in Japan is unlikely. On May 21, the vaccine subcommittee continued to discuss what should be done with the AstraZeneca vaccine. It is not yet clear when a decision will be made on the matter, the Health Ministry said. With so many people waiting to be vaccinated, one expert argues that the government should not ignore any vaccine. Otherwise, the Japanese public, with the exception of the elderly, will not receive any vaccines until the fall. “We may not even get there by the end of the year,” Gakushuin University economics professor Wataru Suzuki wrote in a commentary for Nikkei . “Certainly people who want to be protected from the virus as soon as possible have a need to be vaccinated, similar to those who want a vaccine passport to be able to travel abroad on business, and the Ministry of Health is going too far by how to eliminate options,” he argued. Where will 120 million doses go? The Japanese government has reached an agreement to purchase 120 million doses of the AstraZeneca vaccine, all manufactured in Japan, using undiluted solutions from the United States. Of these, 30 million will be manufactured by Daiichi Sankyo and KM Biologics, and 90 million doses will be manufactured by JCR Pharmaceuticals. However, it is not clear how many of these vaccines have been produced Nikkei Asia. Imports and production begin this spring. Daiichi Sankyo and KM are both preparing to ship the vaccine once it is approved by the government. The mid-range drug maker has started production using equipment and technology from AstraZeneca. JCR has announced plans to build a new factory. The US and Japan will have to find a way to handle the 120 million doses of the coronavirus vaccine developed by the Universities of Oxford and AstraZeneca without any plans to use them. Photo: Reuters. AstraZeneca says its completed vaccine can be stored in the refrigerator for at least half a year at 2-8 degrees Celsius. It’s uncertain at this point how many vaccines are ready to be manufactured. If there is no decision on where to use the vaccine in the next six months, the stockpile could expire. The US has yet to start rolling out the AstraZeneca vaccine. However, the country has agreed to purchase 300 million doses and already has shipments ready to deliver. Currently, the US plans to ship the unused vaccine elsewhere.

Australia ordered 25 million doses of Moderna’s vaccine. AAP photo. Moderna pharmaceutical company said Australia will receive two batches of vaccines, including a booster batch of vaccine capable of dealing with new variants of the SARS-CoV-2 virus. Moderna CEO Stephane Bancel also said that the company intends to set up a vaccine production facility in Australia this year and this intention is being discussed by the company with the Australian government. Moderna’s Covid-19 vaccine has not been approved in Australia, but the company said it will quickly submit an application to the Therapeutic Goods Administration for approval. Moderna’s vaccine is manufactured on the same mRNA technology platform as Pfizer’s vaccine and is considered highly effective in preventing deaths and hospitalizations due to Covid-19. Moderna’s vaccine has not yet been approved for use by the Australian Drug Administration, but it is being used widely in vaccination programs in the US. Thus, with the agreement with Moderna, Australia has ordered a total of nearly 200 million doses of Covid-19 vaccine, enough to vaccinate nearly four times the population of this country.

Previously, on February 24, more than 117,000 doses of Covid-19 vaccine were first produced by the British AstraZeneca Company, and imported by the Vietnam Vaccine Joint Stock Company (VNVC) under the permission of the Ministry of Health. present in Vietnam. Next, on April 1, 811,200, the first Covid-19 vaccine dose of the Covax Facility program through UNICEF arrived in Vietnam. By the end of May 12, the whole country had 62 provinces and cities completed the vaccination of Covid-19 with 942,030 injections of Covid-19 vaccine of AstraZeneca for people who are health workers. are directly treating Covid-19 patients, medical staff perform tasks such as sampling, testing, tracing, members of Covid-19 community groups, steering committee for epidemic prevention all levels, police forces, the army according to the Resolution 21 / NQ-CP of the Government dated February 26, 2021. Step 1: Access to https://www.bluezone.gov.vn or directly download at App Store or Play Store. Step 2: Once downloaded, the app will ask for Bluetooth permission to record contact with other Bluezone installed users. If Bluetooth isn’t open, drag the status notification bar and turn on Bluetooth; Or go to Settings, select Bluetooth and turn it on. Step 3: After the installation is complete, click Scan Around. If someone near you less than 2m has used Bluezone, the application will automatically identify these users and put them on the contact list.

The manufacturers BioNTech and Pfizer want to deliver an additional 50 million doses of corona vaccine to Germany and the other EU countries by the end of June. This was announced by the EU Commission chief Ursula von der Leyen in Brussels. It is a delivery that will be brought forward from the fourth quarter. In the second quarter from April to June, a total of 250 million doses of vaccine would come from BioNTech / Pfizer, said von der Leyen. The delivery will be distributed to the 27 EU countries according to the proportion of the population, she added. For Germany this is 18.6 percent. The Federal Republic of Germany can therefore expect a good nine million cans from the additional delivery. This could partially offset potential failures in Johnson & Johnson’s vaccine. The US manufacturer had postponed its delivery to the EU countries on Tuesday. The background to this are reports of sinus vein thrombosis. The group is investigating the cases, and the European Medicines Agency (EMA) is also examining them. It is unclear when deliveries will resume in Europe.

Negotiations over 1.8 billion vaccine doses

Von der Leyen also announced negotiations with BioNTech / Pfizer for the delivery of a further 1.8 billion vaccine doses for the period from 2021 to 2023. These should be used for refresher courses and vaccinations for children. Part of the agreements should be a full EU manufacture, not just of the vaccine, but of all the essential ingredients, as von der Leyen said. They hope that the negotiations will be concluded quickly. Von der Leyen emphasized that they wanted to focus on vaccine technologies that had proven their worth. That speaks in favor of mRNA vaccines like those produced by BioNTech / Pfizer. AstraZeneca and Johnson & Johnson, on the other hand, use a different mode of action for their vaccines with the help of so-called adenoviruses. Von der Leyen also announced that the EU has now passed the 100 million vaccination threshold. 26 million people are now fully vaccinated with two doses. “This is a milestone that we can be proud of,” said the German politician. The Commission is doing everything possible to increase the supply of vaccines in the coming weeks and months.